Healthcare Analytical Testing Services Market to reach USD 19.14 billion by 2032 at CAGR of 11.21%
The global healthcare analytical testing services market is witnessing robust growth due to the increasing complexity of pharmaceutical products and the need for rigorous testing to meet stringent regulatory requirements. For instance, according to recent studies, over 40% of new drug approvals by the U.S. FDA in 2022 were biologics, requiring advanced analytical techniques for characterization and stability testing. Biologics’ sensitivity to environmental factors has intensified the demand for sophisticated testing solutions, including high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy, which enable precise analysis of molecular structures.